Serve is effectively underwriting a utilization inflection: once a city has enough robots + ops density, incremental deliveries scale faster than headcount. The
Diligent (
Moxi) hospital line is strategically valuable because it adds a second, less platform-mediated demand surface and can share the autonomy/ops stack. If Serve proves reliability and can contract for volume (not just route opportunistically), the market can
re-rate it from “pilot economics” to “automation lane” economics.